Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • GSK vs CP✓SelectedUSD · CPGSK vs CP performance historyLatest closeAs of+2.40%11/09
Stock and ETF performance explorer

GSK vs CP

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+100.5%
CP return
+261.0%
Excess return
-160.5%
Maximum drawdown
-37.6%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 10y.

Portfolio and benchmark returns by period
PeriodPortfolioCPExcessAlpha
1D+2.4%+2.0%+0.4%+1.8%
7D+4.9%+2.8%+2.1%+4.1%
30D+10.8%+11.3%-0.5%+7.5%
3M-1.8%+2.9%-4.7%-2.6%
6M+4.1%+9.8%-5.7%+1.2%
YTD+7.9%+28.5%-20.7%+0.1%
1Y+14.4%+33.5%-19.1%+5.1%
3Y+68.1%+31.9%+36.2%+52.8%
5Y+47.7%+25.5%+22.2%+33.8%
10Y+100.5%+257.6%-157.1%+36.2%
All+100.5%+261.0%-160.5%+36.2%

Cumulative growth

Daily Returns

Daily percentage return beside CP.

Daily Out/Under-Performance

Portfolio return minus CP return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × CP return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 10y: compounded portfolio wealth divided by compounded CP wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

10y analysis · Full analysis span regression · 6 months rolling